Described is the development of a fluoroimmunoassay for theophylline using a fluorescein labelled derivative of theophylline as tracer and antibodies coupled to magnetisable solid-phase particles. Three approaches are described for the preparation of antibodies for theophylline, of which one produced highly specific, high titre antibodies. The fluoroimmunoassay using these antibodies required a 10 μL sample, reached equilibrium within 5 min, and the results correlated closely with those of an established enzymoimmunoassay method. Potentially interfering endogenous fluorophores from the serum sample were reliably removed at the separation step of the bound and free fractions. There was no significant cross-reactivity with all other structurally related compounds.
References
1.
RallTW. In: GilmanAGGoodmanLSGilmanA, eds. The Pharmacological Basis of Therapeutics, New York: Macmillan Publishing Co Inc., 1980; 592–607.
2.
ShannonDCGotayFSteinIRogersMMoylanFMB.Prevention of apnea and bradycardia in low-birth-weight infants. Pediatrics1975; 55: 589–94.
3.
HendelesLWeinbergerMWyattR.Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child1978; 132: 876–80.
4.
JacobsMHSeniorRMKesslerG.Clinical experience with theophylline. Relationships between dosage, serum concentrations and toxicity. J Am Med AsSoc.1976; 235: 1983–6.
WeinbergerMHendelesLJohnsonG.Rationale and procedures for measuring serum levels of theophylline. In: BaerDMDitoWR, eds. Interpretation of Therapeutic Drug Monitoring, Chicago: American Society of Clinical Pharmacology, 1981; 98–137.
7.
SmithFA.Therapeutic drug monitoring of theophylline, salicylates and acetaminophen. In: HenryJG, ed. Clinics in Laboratory Medicine, Volume 1, Philadelphia: WB Saunders Co, 1981; 559–69.
8.
CookCETwineMMyersMAmersonEKeplerJATaylorGF.Theophylline radioimmunoassay: Synthesis of antigen and characterisation of antiserum. Res Comm Chem Pathol Pharmacol1976; 13: 497–505.
9.
SinghPHuMWGushawJBUllmanEF.Specific antibodies to theophylline for use in a homogeneous immunoassay. J Immunoassay1980; 1: 309–22.
10.
NashikawaTSaitoMKuboH.Preparation of anti-theophylline antiserum and determination of theophylline in patient blood by radioimmunoassay method. Chem Pharm Bull1979; 27: 893–8.
11.
PourfarzanehMKamelRSLandonJDawesCC.The use of magnetisable particles in solid phase immunoassay. In: GlickD, ed. Methods in Biochemical Analysis.Volume 28. New York: John Wiley, 1982, 281–3.
12.
HuMWSinghPUllmanEF.Use of (pivaloyloxy) methyl as a protecting group in the synthesis of antigenic theophylline (1,3-dimethyxanthine) derivatives. J Org Chem1980; 45: 1711–3.
13.
Al-HakienMHHWhiteGWSmithDSLandonJ.Direct determination of propranolol in serum or plasma by fluoroimmunoassay. Ther Drug Monit1981; 3: 159–65.
14.
ChangJGorcherSGushawJB, Homogenous enzyme immunoassay for theophylline in serum and plasma. Clin Chem1982; 28: 361–7.
15.
KamelRSLandonJSmithDS.Anti-drug sera raised by immunisation with a readily available drug-enzyme conjugate. Clin Chim Acta1978; 84: 403–5.
16.
SidkiAMRowellFJLandonJ.Direct determination of primidone in serum or plasma by a magnetisable solid-phase fluoroimmunoassay. Ann Clin Biochem1983; 20: 227–32.
17.
PourfarzanehMWhiteGWLandonJSmithDS.Cortisol directly determined in serum by fluoroimmunoassay with magnetisable solid phase. Clin Chem1980; 26: 730–3.
18.
NargessiRDAcklandJHassanMForrestGCSmithDSLandonJ.Magnetisable solid-phase fluoroimmunoassay of thyroxine by a sequential addition technique. Clin Chem1980; 26: 1701–3.
19.
AbrahamGE.Solid-phase radioimmunoassay of estradiol-17B. J Clin Endocrinol Metab1969; 29: 866–70.
20.
SmithDSAl-HakiemMHHLandonJ.A review of fluoroimmunoassay and immunofluorometric assay. Ann Clin Biochem1981; 18: 253–74.
